ReGenX Biosciences Pipeline
| Drug | Indication | Phase |
|---|
| RGX-314 | Wet Age-Related Macular Degeneration (wAMD) | Phase II |
| RGX-121 | Mucopolysaccharidosis Type II (MPS II) | Phase I/II |
| RGX-181 | CLN2 Disease (Batten Disease) | Phase I/II |
| RGX-111 | Mucopolysaccharidosis Type I (MPS I) | Phase I/II |
| RGX-381 | Ocular manifestations of Epidermolysis Bullosa | Phase I/II |